preloder

Company History

/Company History
Company History2018-12-17T10:03:13+03:00

2019. Completion of engineering

2019. Completion of engineering

The company carries out the second stage of construction (engineering) and completes the rebranding project.

2018. The New Plant

2018. The New Plant

Samson-Med completes the first stage of construction of a new plant and starts a rebranding project.

2017. The 80th Anniversary

2017. The 80th Anniversary

The company celebrates its 80th anniversary.
The project of new facility construction is actively implemented.
Samson-Med co-operates with leading research institutes to develop and study new products.

2016. Strategic Importance

2016. Strategic Importance

Samson-Med becomes a resident of St. Petersburg Import Substitution and Localisation Centre.
St. Petersburg Government recognises the strategic importance of the construction project in the Decree.

2010. Pharmaceutical Cluster

2010. Pharmaceutical Cluster

Samson-Med becomes a participant of St. Petersburg pharmaceutical cluster

2010. The Historic Agreement

2010. The Historic Agreement

The agreement about the construction of new production facility of Samson-Med signed by the Government of St. Petersburg.

2009. The decision to expand

2009. The decision to expand

The company decided to build a new production facility

1997. Samprost® production started

1997. Samprost® production started

Samson-Med begins to produce Samprost®

1990. Two new products launch

1990. Two new products launch

The company completed development, registration and started to produce Mafusol and Polyoxifumarinum blood-substitution liquids.

1982. Thymalin® product launch

1982. Thymalin® product launch

The company starts to produce Thymalin®

1978. Cytochrome C launch

1978. Cytochrome C launch

Completion of the development and start of production of the injection form of Cytochrome C

1972. Plasma substitutes launch

1972. Plasma substitutes launch

The company begins production of plasma-substituting medicines (Disole, Trisole, Acesole), registration and start of production of Trypsin crystallisatum

1966-1969. Three new products launched

1966-1969. Three new products launched

Company starts production of gelatinolum, Desoxyribonuclease and Pilocarpinum.

1963. Chymopsin and Chymotrypsin production

1963. Chymopsin and Chymotrypsin production

Company starts production of Chymopsin and crystallised Chymotrypsin.

1941-1945. During the War.

1941-1945. During the War.

Company starts production of penicillin and insulin.

1937. Company Foundation

1937. Company Foundation

SamsonMed founded in 1937.